Lockitt.....you left off the third possibilty.......good for us, no change for us or.....bad for usso far its looking grim. They lost 25% of their SP on top of the continuing down trend since....well forever.RegardsRob 440
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%